About AloftAce Group

AloftAce is a global tech-driven original manufacturer specializing in R&D, production and worldwide operation of AI-powered intelligent health detection devices for the preventive wellness sector, delivering compliant, actionable solutions for global health institutions and channel partners.

 

We address core industry pain points: high-end equipment has prohibitive barriers for SMEs, while entry-level devices lack sufficient precision. Our core product delivers professional-grade high-precision testing of 293 health indicators, with in-depth software customization and open API embedding support, to help clients build differentiated competitiveness.

 

We are recruiting exclusive regional distributors, resellers and OEM/ODM partners globally. With CE, FCC, EAC, ISO9001 and FDA registration, we provide high-margin factory-direct supply, regional protection and full operational support, backed by strict quality control for our global clients.

Our Service
Full-Cycle Empowerment, Grow with Partners
Pre-Cooperation Solutions
Tech Training & Empowerment
Local Operation Support
After-Sales & Tech Update
Partner Growth Incentives
Pre-Cooperation Consulting & Customized Solution Service
Our full partner support services include:

01. We provide one-on-one exclusive consulting services for every intended partner, deeply matching your regional market characteristics, store scale and business needs, and providing customized commercial health testing solutions; as a source R&D enterprise of software systems, we also offer professional software customization support, including API embedding, cloud data retrieval and data secondary development.

 

02. We provide a full set of compliance documents and product testing reports, answer all-dimensional questions such as regional agency policies, sample applications, and stocking plans, helping you quickly understand market thresholds and reduce entry risks.

Core Development Milestones
2018
AloftAce was officially established, the core R&D team was formed, and the AI intelligent health detection algorithm R&D project was launched
2019
The 1st generation AI intelligent health detection algorithm was developed, and the first 3 national invention patents were authorized
2020
The 1st generation AI intelligent health detector was officially launched, and passed the ISO9001 quality management system certification
2021
Completed EU CE (EMC, ROSH, LVD) and US FCC certification for core products, and officially launched the global market layout
2022
The 2nd generation AI intelligent health detector was upgraded, obtained Russian EAC certification, officially entered the Eurasian market, and global partners exceeded 100
2023
Awarded as National High-tech Enterprise and Guangdong Specialized, Refined, Characteristic and Innovative Enterprise, with a total of 16 independent invention patents
2024
The 3rd generation product was fully upgraded, with global sales covering more than 30 countries and regions, and strategic cooperative customers exceeding 200
2025
The 4th generation high-end intelligent algorithm was iterated, 3 new core invention patents were added, reaching a total of 19, and the 2026 global channel investment promotion support plan was officially released
2026
The new generation of AI intelligent health detector was released globally, adapted to 12 major languages, and the global channel investment promotion was fully upgraded